FDA Week - 06/26/2020

HHS, Drug Makers Working On Plan For Leftover Hydroxychloroquine

By Beth Wang / June 23, 2020 at 4:00 PM
HHS and drug makers that donated hydroxychloroquine and chloroquine to the national stockpile are determining what to do with leftover inventory, an HHS spokesperson said. One lawyer suggested that companies consider taking back the hydroxychloroquine and sending it to countries with high rates of malaria. After President Donald Trump touted the antimalarial drugs for treating and preventing COVID-19, FDA authorized them for emergency use in COVID-19 patients , which allowed the government to distribute stockpiles to hospitals. But FDA subsequently...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.